ZAI LAB LIMITED Inventory, Raw Materials, Gross
ZAI LAB LIMITED (ZLAB) had Inventory, Raw Materials, Gross of $20.40 million as of 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Notes › Inventory, Gross
us-gaap:InventoryRawMaterials · last filed 2022-11-09
- 2022-09-30: Inventory, Raw Materials, Gross $20.40M.
- 2022-06-30: Inventory, Raw Materials, Gross $18.48M.
- 2022-03-31: Inventory, Raw Materials, Gross $15.55M.
- 2021-12-31: Inventory, Raw Materials, Gross $13.23M.
| Period end | Inventory, Raw Materials, Gross |
|---|---|
| 2022-09-30 | $20.40M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $18.48M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $15.55M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $13.23M 10-Q · filed 2022-11-09 |
| 2021-09-30 | $7.20M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $6.27M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $9.59M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $10.10M 10-K · filed 2022-03-01 |
| 2020-06-30 | $5.74M 6-K · filed 2020-09-11 |
| 2019-12-31 | $5.41M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |